Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2022 2
2023 2
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study.
Sousa-Pinto B, Ramanauskaite A, Neisinger S, Witte-Händel E, Gimenez-Arnau AM, Guillet C, Parisi CAS, Katelaris CH, Fomina D, Larenas-Linnemann D, García E, Kocatürk E, Siebenhaar F, Lima H, Kaidashev I, Nasr I, Canales IO, Ojeda IC, Hébert J, Bousquet J, Bernstein JA, Peter J, Sanchez J, Sousa JIL, Kulthanan K, Weller K, Godse K, Rutkowski K, Lapina L, Bouillet L, Han LL, Ensina LF, Gonçalo M, Magerl M, van Doorn M, Metz M, Khoshkhui M, Hide M, Türk M, Kurjāne N, Conlon N, Salameh P, Kolkhir P, Asero R, Stepanenko R, Altrichter S, Gil-Mata S, Thomsen SF, Zuberbier T, Tsaryk V, Ye YM, Brzoza Z, Zhao Z, Maurer M. Sousa-Pinto B, et al. Among authors: ojeda ic. Allergy. 2025 Mar;80(3):750-761. doi: 10.1111/all.16371. Epub 2024 Oct 24. Allergy. 2025. PMID: 39445583
CRUSE - What the first 100 days have taught us.
Neisinger S, Pinto BS, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Ojeda IC, Gimenez-Arnau AM, Maurer M. Neisinger S, et al. Among authors: ojeda ic. Qatar Med J. 2023 Nov 19;2023(2):14. doi: 10.5339/qmj.2023.sqac.14. eCollection 2023. Qatar Med J. 2023. PMID: 38025340 Free PMC article.
Exploring the impact of chronic urticaria profile as a key predictor of alexithymia: A cross-sectional study.
Ojeda IC, Thomsen SF, Gimenez-Arnau AM, Sørensen JA, Lima H, Godse K, Guillet C, Escalante L, Maldonado A, Chorzepa GF, Morfin-Maciel B, Larco Sousa JI, de Arruda-Chaves E, De A, Fomina D, Patil A, Criado RJ, Ensina LF, Valle SOR, Agondi RC, Chong Neto H, Rosario N, Ramon GD, Faytong-Haro M, Ogueta I, Moran IT, Donnelly J, Kocatürk E, Zalewska-Janowska A, Robles-Velasco K. Ojeda IC, et al. Clin Transl Allergy. 2025 Jul;15(7):e70075. doi: 10.1002/clt2.70075. Clin Transl Allergy. 2025. PMID: 40616233 Free PMC article.
Multinational experience with hypersensitivity drug reactions in Latin America.
Jares EJ, Sánchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cruz A, Gómez M, Barayazarra S, Bernstein JA, Serrano CD, Cuello MN, Morfin-Maciel BM, De Falco A, Cherrez-Ojeda I; Latin America Drug Allergy Interest Group. Jares EJ, et al. Ann Allergy Asthma Immunol. 2014 Sep;113(3):282-9. doi: 10.1016/j.anai.2014.06.019. Epub 2014 Jul 24. Ann Allergy Asthma Immunol. 2014. PMID: 25065979